Patients with neurodegenerative disease show distinct patterns of personality change, some of which may be traced to focal neurological damage, whereas others may be mediated by cultural reactions to functional impairment. Although such changes are early and pervasive in behavioral variant frontotemporal dementia (bvFTD), and milder changes are seen in Alzheimer disease (AD), no study has examined all Big 5 factors of personality in mild cognitive impairment (MCI) patients. In addition, the influence of culture and ethnicity on disease-related personality changes has seldom been examined. Premorbid and current personality were measured in 47
P ersonality traits are mostly consistent in adulthood and old age, although small shifts in personality occur across the life span. [1] [2] [3] Although there are many personality theories in use today, the 5-Factor Theory is perhaps the most comprehensive and widely used theory of normal personality, and its factors (openness, conscientiousness, extraversion, agreeableness, and neuroticism) seem to emerge quite consistently across cultures. [4] [5] [6] This model has also frequently been used to measure personality of adults in later life. [7] [8] [9] [10] Although several longitudinal studies have revealed substantial consistency in Big 5 personality traits continuing into old age, there do seem to be small but significant group changes in certain traits, such as increases in neuroticism and agreeableness and decreased extraversion and openness in healthy older subjects. 11 Other studies reveal increased agreeableness and conscientiousness and a decrease in openness in later life. 3, 12 Although these small shifts may occur on a group level as a function of normal aging, large changes in personality are not typical and may signify underlying neurological disease. 10 In particular, uniform, unidirectional changes in personality occurring in the majority of individuals with a specific medical condition or disease are likely to derive from processes unique to the disease itself. These may be culturally mediated reactions (eg, aphasic patients who are unable to communicate in social interactions may become more introverted) or direct neurological sequelae (eg, patients with focal damage to frontal structures that mediate social dominance may become more introverted). For instance, recent studies have demonstrated that patients with neurodegenerative disease show distinct patterns of personality change that are disease specific, which can also be directly traced to focal neurological damage. 13, 14 Personality change is a core and early feature of behavioral variant frontotemporal dementia (bvFTD). 15 Recent studies suggest that change may occur in all the 5 personality factors in bvFTD, with agreement across studies that significant decreases in conscientiousness occur in relation to healthy controls, with mixed findings suggesting that bvFTD patients may also have decreased openness, extraversion, and neuroticism in comparison with both normal controls and Alzheimer disease (AD) patients. 14, 16 The studies using different personality measures have found decreased agreeableness in bvFTD, 14, 17, 18 a change that has been linked to medial orbitofrontal volume loss.
Personality change in AD patients is less marked when compared with bvFTD, as the frontal and anterior medial temporal areas primarily affected in bvFTD are relatively spared in AD. However, AD patients often present with significant changes in personality, showing increased neuroticism and a decrease in extraversion, openness, and conscientiousness, 7-9 with mixed results on loss of agreeableness. 19, 20 There is some evidence that these changes wax and wane in predictable patterns over the course of the disease. 21 Although some of these recent studies suggest that such changes may occur early in the disease process and may be observable even at the mild cognitive impairment (MCI) stage, 22 studies have not yet examined all of the Big 5 factors in MCI patients.
The influence of culture and ethnicity on these agerelated and disease-related personality changes has seldom been examined. There have been efforts to measure the personality of healthy Greek adults throughout the adult life span and to compare their personality traits with those of other cultures. These have primarily used Big 5-based measures such as the NEO-PI or the Traits Personality Questionnaire (TPQue), 23 a Greek language 5-factor selfreport questionnaire developed by Tsaousis to explicitly account for ethnic and cultural characteristics found among Greek people. However, to our knowledge, in Greece, there has been no research focusing on personality change in older adults suffering from neurodegenerative diseases.
This study examined personality changes appearing in patients with AD, bvFTD, and MCI compared with their premorbid personality using the TPQue5, the shortened version of a Greek measure of the 5-factor model of personality. 24 On the basis of the findings of previous studies in other cultures, we expected to find that when current and premorbid states of our subjects were compared in order to derive a measure of personality change, distinct and predictable patterns of personality changes would occur for the 3 diagnostic groups. We predicted that AD patients would show a significant increase in neuroticism and a decrease in extraversion, conscientiousness, and openness. Further, we hypothesized that bvFTD patients would show decreases in these 4 factors and also in agreeableness, whereas no significant personality changes were expected in any of the 5 factors for the MCI group.
METHODS Subjects
A total of 42 patients, 8 of whom were diagnosed with bvFTD on the basis of the Neary consensus criteria, 15 17 with AD on the basis of the NINCDS-ADRDA criteria 25 and 17 with MCI on the basis of the Petersen criteria 26 were recruited into the study. These criteria were used to exclude MCI patients whose pattern of cognitive deficits was inconsistent with early AD, such as executive MCI. The MCI patients were included only if memory deficits were their primary domain of impairment, although patients were not excluded if they had some additional nonmemory impairments. Age, education, and sex distribution within the subject groups can be found in Table 1 .
Procedures
Patients were identified by diagnosis from a pool of clinic patients and were then recruited as study participants, consenting to undergo additional research tests, and agreeing for their clinical data to be analyzed for research purposes. The study was approved by appropriate authorities at the Athens General Hospital to assure ethical treatment of the participants. A complete multidisciplinary diagnostic evaluation was performed, including a neurological examination, clinical interview with patients and caregivers, and neuropsychiatric evaluation. The subjects underwent a comprehensive battery of functional, neuropsychological, social cognition, and personality tests.
There is substantial evidence that patients with AD and bvFTD are likely to provide inaccurate self-assessments because of insight-related cognitive deficits; thus, their self-reports were not deemed reliable, and personality evaluation was obtained from a caregiver informant (see a more detailed rationale for this procedure elsewhere 27 ). Caregiver informants completed the TPQue5 twice, first describing the subjects' current personality traits and then their premorbid personality traits. For the retrospective account, informants were asked to describe the subjects "before they became ill."
Measures
The TPQue5 24 is a measure of the Big 5-Factor model of personality, including scales measuring openness, conscientiousness, extraversion, agreeableness, and neuroticism, as well as lie and social desirability scales. It is a short version (101 items) of the TPQue, 23 which was developed and validated specifically for use with the Greek adults. Factor analysis of the TPQue5 short form demonstrates that it maintains the original factors and displays good internal consistency [a's for split-half reliability ranging from 0.73 (openness) to 0.85 (neuroticism)] and excellent test-retest reliability [intraclass correlation coefficients ranging from 0.71 (agreeableness) to 0.86 (conscientiousness)]. The TPQue5 was preferable to the TPQue for this study because our aging and low-education population respond better to its short length.
The control sample developed to standardize the TPQue5 consisted of 735 primarily young Greek university students with age ranging from 18 to 55 years (mean = 27.1, SD = 9.7). Standardized, sex-specific T-scores were generated for all the subjects on the basis of this normative sample. 23, 24 Neuropsychological testing included measures of all the major cognitive domains (Table 1) , which have been detailed elsewhere. 28 The functional and neuropsychiatric measures included the Alzheimer's Disease Cooperative Study-Activities of Daily Living, the Geriatric Depression Scale, 29 the Neuropsychiatric Inventory Total Score, 30 the Mini-Mental State Examination (MMSE), and the Addenbrooke's Cognitive Examination-Revised. 31 
Data Analyses
General linear models were used to compare the 3 groups for possible confounding effects of age, education, and disease severity (represented as the MMSE score), and w 2 tests were used to test for group differences in sex. Although sex and age were equally represented across all diagnostic groups, education level and an MMSE showed significant group differences, and thus were included as confounding covariates in all the analyses of personality, neuropsychological, neuropsychiatric, and functional measures.
All interpersonal trait scores are reported in the form of standardized T-scores that were calculated on the basis of comparison with the Greek normative sample described earlier. 23, 24 Thus, scores were considered clinically abnormal if the values were >1.5 SD from the mean, that is, scores below 35 (sixth percentile) or above 65 (94th percentile). Statistically significant differences between the scores (eg, significant change over time or between the groups) are also reported regardless of whether the scores were outside of this clinically normal range.
To appropriately handle the repeated nature of the personality data, a random coefficients model using SAS Proc Mixed 32 was used to generate estimates of the 5 personality scores for each diagnostic group for both the premorbid stage (informants' retrospective account) and current stage of the disease.
RESULTS

Premorbid Scores
All premorbid personality factor scores of the MCI, AD, and bvFTD groups were within the clinically normal range (ie, T-score range of 35 to 65), suggesting that according to the informants' retrospective reports, all subjects began within the range of normal personality ( Table 2) . MCI subjects were at the upper limit of normal conscientiousness [T = 64.0 (SD = 3.0)] and upon statistical comparison, had significantly higher conscientiousness scores compared with the bvFTD subjects [T = 52.5 (SD = 3.9)] (P < 0.05). No other personality factors showed premorbid differences across the disease groups. It is unclear whether this difference reflects a true difference in premorbid personality across the diagnostic groups or whether it is because of the informants' uncertainty in estimating the time of symptom onset in the bvFTD patients (ie, their "before" ratings may have reflected a time at which the bvFTD patients were already losing conscientiousness, albeit at a clinically insignificant level). In addition, this sample diverged substantially from the expected average group T-score around 50, which suggests that our patient sample may be fundamentally different from the younger, highly educated control subjects on which the TPQue5 is standardized. Because of this, caution should be used in interpreting patient group scores found to be clinically abnormal (ie, falling outside of the +/À1.5 SD range described earlier).
Personality Change and Group Differences
Openness
The subjects' scores for openness to new experiences were at the lower limit of normal for both retrospective premorbid ratings and current ratings, ranging from 38.4 . No group's scores changed significantly between the "before" and "current" time points, and no disease group had significantly different scores from any other disease group (Fig. 1 ).
Conscientiousness
The current scores for conscientiousness were within clinically normal range for both MCI and AD patients, whereas bvFTD patients' current scores were abnormally low (T = 28.2). All groups' scores dropped significantly at the current time point (P < 0.001), and both AD and bvFTD patients' current scores were significantly lower compared with those of MCI patients. bvFTD patients were also rated significantly lower in conscientiousness compared with the AD patients (P < 0.05).
Extraversion
The subjects' scores for extraversion were within normal limits for the 3 groups' retrospective premorbid ratings. There was a statistically significant drop in all the groups' scores between the premorbid and current state of disease, leading to clinically low scores for the AD and bvFTD patient's current ratings. No significant differences were statistically noted among the different disease groups.
Agreeableness
Premorbid scores for agreeableness were within a clinically normal range for all disease groups. Although all groups' agreeableness dropped between premorbid and current time points, this change was only significant for the AD patients (P < 0.05). AD patients also scored significantly lower compared with MCI patients at the current time point.
Neuroticism
Although all the groups started within a normal range for retrospective premorbid ratings, AD and MCI patients were rated as significantly more neurotic currently (P < 0.005), whereas bvFTD patients were rated as less neurotic than they had been premorbidly. The current ratings for bvFTD patients' neuroticism were significantly lower compared with either AD or MCI patients.
DISCUSSION
As expected, examination of personality change in
Greek AD, bvFTD, and MCI patients with a Big 5 measure revealed significant personality changes on most factors, with divergent patterns across the groups. The bvFTD patients' decrease in conscientiousness was significantly bigger compared with the decrease noted for the AD and Personality in Greek Patients With AD, bvFTD, MCI MCI patients. In addition, the changes noted in neuroticism for the 3 groups followed divergent paths: a significant increase was observed for the AD and MCI groups, whereas the bvFTD patients were rated as having become much less neurotic in the course of their disease. MCI patients unexpectedly presented with a decrease in conscientiousness and extraversion and an increase in neuroticism, a pattern of change very similar to that of AD patients. These results suggest that predictable patterns of personality change do occur as a result of the disease process. These changes were seen in a Mediterranean sample that diverges culturally from the European and the North and South American populations in which such personality changes have previously been observed, which supports the argument that neurological factors superseding cultural environment may be involved. Although nonbiological factors (eg, a psychological reaction to becoming ill) may have influenced these group-level changes in personality across the cultures, degenerative changes in specific neuroanatomic regions likely play a significant role. 13, 14 Personality Change in bvFTD
The bvFTD group showed significant decreases in conscientiousness and extraversion, which are findings common to other neurodegenerative diseases. [7] [8] [9] Although there was a quantitative drop in agreeableness in this group, these changes were not statistically significant in our sample, despite evidence from previous reports indicating that bvFTD patients become significantly more disagreeable in the course of their disease. 14, 17, 18 The previous research has occurred primarily with fairly high functioning bvFTD patients, whereas the mean MMSE of this sample averaged 17.6/30, suggesting patients were at a moderate level of disease severity. If loss of agreeableness occurs early in the disease as a result of behavioral disinhibition, but becomes less apparent as patients become more apathetic with advancing disease, then this may cause the group average for agreeableness to be diminished in a sample consisting of more advanced bvFTD patients. The wider SDs on personality measures seen in our bvFTD patients, compared with the other groups, might be the evidence that this group included patients at many levels of disease severity.
Unlike the other 2 groups, bvFTD patients' neuroticism decreased to a clinically abnormal level compared with levels typically seen in controls. Gradual lack of reactivity to social or emotional context is very characteristic of bvFTD patients. They lose sensitivity to criticism, exhibit diminished insight 33 and self-awareness, 27 as well as diminished self-conscious emotional responding 34 even in the context of a most dramatic event. Thus, they are less likely to appear anxious or depressed or to experience shyness or feelings of guilt. This decrease in neuroticism has also been seen in a sample of bvFTD patients in Great Britain. 14 Our results reflect a clear uniformity in our groups' premorbid personality factor scores, within the range of normal personality. However, we saw unexpectedly high levels of conscientiousness and low levels of openness across groups at the premorbid stage, even to the point where bvFTDs were significantly lower compared with MCIs in conscientiousness premorbidly. This difference could be the reflection of a random true difference in premorbid personality across the diagnostic groups, either because of a systematic bias in the individuals represented in this relatively small sample or because of a diseaserelated difference in premorbid personality in which some individuals who later develop bvFTD have a lifelong pattern of poor conscientiousness. However, it may also be reasoned that this result is because of informants' uncertainty in estimating the time of symptom onset in the bvFTD patients. This explanation seems more plausible considering the recent findings showing that the Greek caregivers seem to underestimate the timing of bvFTD patients' first symptoms, placing them approximately 6 years later compared with the caregivers in the United States. The authors suggest that the initial behavioral symptoms of bvFTD are ignored or are more likely to be accepted as a normal part of life in Greece. 35 This retrospective bias among the Greek caregivers may have exerted a systematic effect on the estimates of change in this study.
Personality Change in AD and MCI
Confirming our hypotheses concerning the AD group, decreases were found in conscientiousness, extraversion, and agreeableness, whereas neuroticism significantly increased. The MCI group showed a very similar pattern of change in the AD patients, in contrast to our expectations.
MCI patients presented with a significant change in 3 of 5 personality factors: a decrease in conscientiousness and extraversion and an increase in neuroticism, supporting recent research suggesting personality change in MCI may occur earlier than it was previously expected. 21, 35 Although the patients diagnosed with MCI do not yet show clear clinical symptoms that would allow prediction of underlying neuropathology, this group was comprised only of patients with an amnestic-only or amnestic-plus pattern of cognitive deficits and were selected to decrease the likelihood that their symptoms were caused by a non-Alzheimer neuropathology. Furthermore, the fact that the MCI group's pattern of personality change, particularly the increase noted in neuroticism, more closely matches the pattern seen in the AD compared with the bvFTD group, provides support for the hypothesis that this group is primarily composed of patients with an underlying AD pathology. In fact, the distinction between pre-AD MCI patients and those already diagnosed with AD is not necessarily clear in clinical practice. There may have also been a diagnostic bias at work in which patients with a higher level of education had the cognitive reserve necessary to compensate and remain functional in their everyday life, explaining the higher mean level of education in the MCI group, whereas lower-educated patients may have been more likely to meet the criteria for early AD.
Looking at the patterns of personality change in the AD and bvFTD groups, it is possible to observe specific traits differentiating them. In particular, the direction of personality change between the 2 groups is opposite for the trait of neuroticism, with a significant increase for the AD patients and a decrease for the bvFTD patients. Recent studies have examined the intrinsically connected brain network involved in evaluation of personally salient information in AD and bvFTD patients. Higher connectivity in this "salience network," which has been associated with higher levels of anxiety in healthy adults, 36 has been seen in AD patients, whereas bvFTD patients show a corresponding decrease of intrinsic connectivity in this network. 37 Although anxiety and neuroticism are not synonymous, trait neuroticism represents one's ability to manage negative emotions; thus, these 2 constructs overlap and may share neural circuitry. The divergence of neuroticism between AD and bvFTD patients may be a clinical marker for this altered functional connectivity, thus may be very useful for differential diagnosis.
No significant differences were found for openness in any of the patient groups. Previous findings for this factor in bvFTD and AD have been mixed. 9, 14, 38 Researchers have found normal decreases in openness observed in the healthy elderly. 1, 10, 11 However, our subjects' scores for openness to new experiences were at the lower limit of normal for both current and retrospective premorbid ratings, with no significant differences between disease groups, which might be explained by the way the elderly are viewed in Greek culture. The openness to experience reflects qualities such as appreciation of art and beauty, receptivity to the inner world of imagination, openness to new experiences on a practical level, openness to inner feelings and emotions, intellectual curiosity, and readiness to reexamine one's own values and those of authority figures. In Greek culture, the elderly would rarely be seen by their family as carrying those traits, as their retreat from an active professional life is usually followed by a retreat from social activity in general. They become less exposed to new, everyday stimuli and therefore are presented with less opportunity to express these traits. Taking into account the fact that our study participants tended to have low to moderate levels of education, were older than 60 years, and the majority were female (71%), we believe that these findings for openness might best be explained by these cultural factors and are less likely to have been directly caused by focal neurodegeneration.
Limitations and Future Directions
This study is limited by the fact that sample sizes were fairly small; thus, we were unable to detect smaller effect sizes. Further, because of resource limitations, we were unable to collect personality data on a healthy older control group for this study. Although our patients' T-scores were derived by standardizing their performance against a large sample of the normal Greek adults, 23, 24 this highly educated and younger control sample was not ideal for this purpose. However, this lack of an age-matched and educationmatched normal control group did not impact our ability to compare the "before" and "after" time points to assess clinical change within patients, nor did it affect our comparisons across disease groups, which were the primary aims of our study. Furthermore, clinical staging for these patients was performed using the MMSE, which is less likely to accurately incorporate the behavioral deficits seen in bvFTD compared with the other staging tools like the Clinical Dementia Rating Scale. Another limitation is the lack of neuroanatomic data for these patients, which may have provided more evidence for why our results did not entirely confirm our literature-based hypotheses. Finally, our patients' education-level differences, although taken into account in our data analyses, could have influenced diagnostic group assignment. A further investigation of personality change of these diagnostic groups over the course of the disease, as well as the disease's effect on personality for patients with different neurodegenerative conditions, would help clarify these issues. A follow-up of our MCI group would allow us to test our hypothesis that these surprisingly early changes for certain personality traits represent a prodrome of AD. If this is the case, personality testing may be a useful new tool supporting early prediction of AD.
CONCLUSIONS
This is the first effort to compare personality changes in bvFTD, AD, and MCI in the Greek population. Our finding that MCI patients present with decreased conscientiousness and extraversion, as well as an increased neuroticism, supports the current research suggesting personality change in MCI may occur earlier than it was previously expected and may represent a prodrome of AD. The discovery that neuroticism changes in opposite directions in bvFTD and AD may prove to be a useful differential diagnostic marker. Our study did not find that agreeableness decreased significantly for bvFTD patients as expected, but further investigation is necessary to better understand how ratings of agreeableness may be subject to cultural, educational, or selection bias factors. Although personality change has long been neglected as a potential clinical marker differentiating neurodegenerative diseases, this study suggests that further investigation of these changes in various cultural milieus is warranted.
